ovel Regenerative Therapy with Autologus Myoblast Sheet for Pediatric Heart Failure patients
Phase 2
Recruiting
- Conditions
- Severe Cardiomyopathy in Pediatric patietns
- Registration Number
- JPRN-UMIN000013941
- Lead Sponsor
- Department of Cardiovascular Surgery, Graduate School of medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have the foillowings. 1)any degenerative muscle diseases. 2)active infection. 3)suffered from any malignant diseases within 5 years 4)infected by HIV, HBV, HCV or HTLV 5)functional single ventricle physiology 6)restrictive cardiomyopathy 7)irreversible hepatic or renal dysfuntion 8)severe mental retardation or chromosomal abnormality 9)severe pulmonary hyper tension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method